Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial — 2013

Título original

Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial — 2013

Leitura editorial

AREDS2 avaliou luteína/zeaxantina e DHA/EPA adicionados ao AREDS; não houve redução significativa na análise principal, mas luteína/zeaxantina foram substitutos mais seguros ao beta-caroteno.

Referência

DOI: 10.1001/jama.2013.4997. PMID: 23644932.